Clinical Trial Update: Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing candesartan with chlorthalidone to losartan with hydrochlorothiazide for essential hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Candesartan (candesartan)
• Chlorthalidone (chlorthalidone)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Losartan (losartan)

Snippet

Sponsor: EMS | Conditions: Essential Arterial Hypertension | Phase 3 | Status: WITHDRAWN